Pneumonia is inflammation of the lungs and fluid collection in the alveoli. The two most common organisms responsible for pneumonia in low-income countries are Streptococcus pneumoniae and Haemophilus influenzae . Children with pneumonia are treated with antibiotics, with hospitalisation and oxygen supplementation required in some cases, depending on disease severity. Accumulation of secretions in the airways due to respiratory infection contributes to the worsening of clinical symptoms and lead
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients aged 35- 60 years. PNEUMONIA SEVERITY INDEX (PORT SCORE) CLASS I TO III Moderate to severe Grades for Severity of a Pulmonary Function Test Abnormality
Exclusion criteria
Exclusion criteria: Patients with secondary pneumonia-that is, as a complication of dysfunction of respiratory muscles, Chronic bronchitis, Emphysema, Asthma Patients with known pulmonary tuberculosis or lung cancer. Intellectually impaired
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Forced Vital Capacity (FVC). Timepoint: Measurements will be repeated after 4 weeks of 1st intervention. Method of measurement: The pulmonary function variables which will be assessed would be the Forced Vital Capacity (FVC) with the use of a spirometer. A brief description about the assessment procedure including technical steps to obtain pulmonary function data and variables will be explained to each subject. After 2–3 tidal breaths, subjects will be asked to inhale deeply to total lung capacity and then immediately exhale rapidly (without any pause) through a disposable mouthpiece until as much air as possible has been expelled from the lungs. The test will be performed with each subject in in high sitting position. The assessment will be repeated 3 times after adequate rest. The average values of the forced vital capacity (FVC) will be recorded.;Forced Expiratory Volume in one second (FEV1). Timepoint: Measurements will be repeated after 4 weeks of 1st intervention. Method of measurement: The pulmonary function variables which will be assessed would be the Forced Expiratory Volume in one second (FEV1) with the use of a spirometer. A brief description about the assessment procedure including technical steps to obtain pulmonary function data and variables will be explained to each subject. After 2–3 tidal breaths, subjects will be asked to inhale deeply to total lung capacity and then immediately exhale rapidly (without any pause) through a disposable mouthpiece until as much air as possible has been expelled from the lungs. The test will be performed with each subject in in high sitting position. The assessment will be repeated 3 times after adequate rest. The average values of forced expiratory volume in the first second (FEV1) will be recorded. | — |
Secondary
| Measure | Time frame |
|---|---|
| The oxygen hemoglobin saturation (SpO2). Timepoint: Measurements will be repeated after 4 weeks of 1st intervention. Method of measurement: The oxygen hemoglobin saturation (SpO2) will be assessed using a non-invasive pulse oximeter. | — |
Countries
Pakistan
Contacts
Riphah international university lahore